Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Am. J. Epidemiol.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hull, H. F.
Right arrow Articles by Milstien, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hull, H. F.
Right arrow Articles by Milstien, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 153, No. 3 : 215-216
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health

ORIGINAL CONTRIBUTIONS

Invited Commentary: Stopping Polio Immunization

Harry F. Hull1,2, R. Bruce Aylward1 and Julie Milstien1

1 Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
2 Present address: The Minnesota Department of Health, Minneapolis, MN.

Abbreviations: IPV, inactivated polio vaccine; OPV, oral polio vaccine; VDPV, vaccine-derived poliovirus; WHO, World Health Organization


   INTRODUCTION
 
As the world comes closer to eradicating wild polioviruses, the question of when and how polio immunization will be stopped increasingly demands our attention. Formal discussions on this issue began with a series of meetings at the World Health Organization (WHO) in Geneva, Switzerland, starting in 1998 and a meeting co-sponsored by WHO and the International Association for Biologicals held in Paris, France, June 28–30, 2000. Participants of the first WHO-convened meeting concluded that vaccination with oral polio vaccine (OPV) should stop and that vaccination with inactivated polio vaccine (IPV) can stop when 1) wild polioviruses have been eradicated, 2) laboratory strains of wild poliovirus have . . . [Full Text of this Article]


   NOTES
 

   REFERENCES
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Am. J. Epidemiol.:

Immunity to Poliomyelitis in the Netherlands
Marina A. E. Conyn-van Spaendonck, Hester E. de Melker, Frithjofna Abbink, Nazrin Elzinga-Gholizadea, Tjeerd G. Kimman, and Ton van Loon
Am. J. Epidemiol. 2001 153: 207-214. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
T. G. Kimman, H. E. de Melker, F. Abbink, N. Elzinga-Gholizadea, T. v. Loon, and M. A. E. Conyn-van Spaendonck
The Authors Respond to Hull et al.
Am. J. Epidemiol., February 1, 2001; 153(3): 217 - 218.
[Full Text] [PDF]